anti-human igm Search Results


peroxidase conjugated goat anti human fc antibody  (R&D Systems)
90
R&D Systems peroxidase conjugated goat anti human fc antibody
Peroxidase Conjugated Goat Anti Human Fc Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/peroxidase conjugated goat anti human fc antibody/product/R&D Systems
Average 90 stars, based on 1 article reviews
peroxidase conjugated goat anti human fc antibody - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
mouse anti human il  (Novus Biologicals)
90
Novus Biologicals mouse anti human il
Mouse Anti Human Il, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti human il/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
mouse anti human il - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
mouse anti human pe  (R&D Systems)
93
R&D Systems mouse anti human pe
Mouse Anti Human Pe, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti human pe/product/R&D Systems
Average 93 stars, based on 1 article reviews
mouse anti human pe - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
rabbit anti human primary antibody  (R&D Systems)
90
R&D Systems rabbit anti human primary antibody
Rabbit Anti Human Primary Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti human primary antibody/product/R&D Systems
Average 90 stars, based on 1 article reviews
rabbit anti human primary antibody - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
goat anti human igm  (R&D Systems)
94
R&D Systems goat anti human igm
Goat Anti Human Igm, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/goat anti human igm/product/R&D Systems
Average 94 stars, based on 1 article reviews
goat anti human igm - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
anti igm antibody  (Novus Biologicals)
92
Novus Biologicals anti igm antibody
Anti Igm Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti igm antibody/product/Novus Biologicals
Average 92 stars, based on 1 article reviews
anti igm antibody - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier
anti human igm hrp  (Novus Biologicals)
91
Novus Biologicals anti human igm hrp
Anti Human Igm Hrp, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti human igm hrp/product/Novus Biologicals
Average 91 stars, based on 1 article reviews
anti human igm hrp - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier
mouse anti human anti ccr7 percp  (R&D Systems)
93
R&D Systems mouse anti human anti ccr7 percp
Characterization of M1- and M2-related phenotypes. Median fluorescence intensity corresponding to (a) M1-related markers TNF- α , IDO enzyme, <t>CCR7,</t> and CD86 and (b) M2-related markers IL-10, arginase I, CD36, and CD163, found in cells harvested from all different polarizing treatments and controls and analyzed by flow cytometry. For THP-1, mock: no stimulated cells; PMA: PMA-only control; M1: PMA + LPS + INF- γ ; M2: PMA + IL-4 + IL-13; and M2 w/o PMA: IL-4 + IL-13. For U937, mock: no stimulated cells; PMA: PMA-only control; M1: PMA + LPS + INF- γ ; M2-A: PMA + IL-4 + IL-13; M2-B: PMA + M-CSF; and M2-C: IL-4 + IL-13. For primary monocytes, mock: no stimulated cells; M1: GM-CSF + LPS + INF- γ ; and M2: M-CSF + IL-4 + IL-13. Asterisks and bars denote statistical significance between conditions. Significant differences ( p ≤ 0.05) found were as follows: in THP-1 cells CD86, M1 versus M2; IL-10, mock versus all the rest of the conditions; arginase I, M1 versus PMA and versus M2 without PMA; CD163, PMA versus all the rest of the conditions and M2 versus M2 without PMA. In U937 cells IDO, M2-A versus mock and versus M2-C; CD86, (PMA, M1, M2-A, and M2-B) versus mock and M2-C; CD163, M1 versus mock and versus M2-C. In primary monocytes IDO and CD86 were significantly different in M1 versus mock and versus M2.
Mouse Anti Human Anti Ccr7 Percp, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti human anti ccr7 percp/product/R&D Systems
Average 93 stars, based on 1 article reviews
mouse anti human anti ccr7 percp - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
goat anti rabbit immunoglobulin  (Bio-Rad)
93
Bio-Rad goat anti rabbit immunoglobulin
Characterization of M1- and M2-related phenotypes. Median fluorescence intensity corresponding to (a) M1-related markers TNF- α , IDO enzyme, <t>CCR7,</t> and CD86 and (b) M2-related markers IL-10, arginase I, CD36, and CD163, found in cells harvested from all different polarizing treatments and controls and analyzed by flow cytometry. For THP-1, mock: no stimulated cells; PMA: PMA-only control; M1: PMA + LPS + INF- γ ; M2: PMA + IL-4 + IL-13; and M2 w/o PMA: IL-4 + IL-13. For U937, mock: no stimulated cells; PMA: PMA-only control; M1: PMA + LPS + INF- γ ; M2-A: PMA + IL-4 + IL-13; M2-B: PMA + M-CSF; and M2-C: IL-4 + IL-13. For primary monocytes, mock: no stimulated cells; M1: GM-CSF + LPS + INF- γ ; and M2: M-CSF + IL-4 + IL-13. Asterisks and bars denote statistical significance between conditions. Significant differences ( p ≤ 0.05) found were as follows: in THP-1 cells CD86, M1 versus M2; IL-10, mock versus all the rest of the conditions; arginase I, M1 versus PMA and versus M2 without PMA; CD163, PMA versus all the rest of the conditions and M2 versus M2 without PMA. In U937 cells IDO, M2-A versus mock and versus M2-C; CD86, (PMA, M1, M2-A, and M2-B) versus mock and M2-C; CD163, M1 versus mock and versus M2-C. In primary monocytes IDO and CD86 were significantly different in M1 versus mock and versus M2.
Goat Anti Rabbit Immunoglobulin, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/goat anti rabbit immunoglobulin/product/Bio-Rad
Average 93 stars, based on 1 article reviews
goat anti rabbit immunoglobulin - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
horseradish peroxidase conjugated goat anti rabbit  (Bio-Rad)
95
Bio-Rad horseradish peroxidase conjugated goat anti rabbit
Characterization of M1- and M2-related phenotypes. Median fluorescence intensity corresponding to (a) M1-related markers TNF- α , IDO enzyme, <t>CCR7,</t> and CD86 and (b) M2-related markers IL-10, arginase I, CD36, and CD163, found in cells harvested from all different polarizing treatments and controls and analyzed by flow cytometry. For THP-1, mock: no stimulated cells; PMA: PMA-only control; M1: PMA + LPS + INF- γ ; M2: PMA + IL-4 + IL-13; and M2 w/o PMA: IL-4 + IL-13. For U937, mock: no stimulated cells; PMA: PMA-only control; M1: PMA + LPS + INF- γ ; M2-A: PMA + IL-4 + IL-13; M2-B: PMA + M-CSF; and M2-C: IL-4 + IL-13. For primary monocytes, mock: no stimulated cells; M1: GM-CSF + LPS + INF- γ ; and M2: M-CSF + IL-4 + IL-13. Asterisks and bars denote statistical significance between conditions. Significant differences ( p ≤ 0.05) found were as follows: in THP-1 cells CD86, M1 versus M2; IL-10, mock versus all the rest of the conditions; arginase I, M1 versus PMA and versus M2 without PMA; CD163, PMA versus all the rest of the conditions and M2 versus M2 without PMA. In U937 cells IDO, M2-A versus mock and versus M2-C; CD86, (PMA, M1, M2-A, and M2-B) versus mock and M2-C; CD163, M1 versus mock and versus M2-C. In primary monocytes IDO and CD86 were significantly different in M1 versus mock and versus M2.
Horseradish Peroxidase Conjugated Goat Anti Rabbit, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/horseradish peroxidase conjugated goat anti rabbit/product/Bio-Rad
Average 95 stars, based on 1 article reviews
horseradish peroxidase conjugated goat anti rabbit - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier
igg fraction  (Valiant Co Ltd)
95
Valiant Co Ltd igg fraction
Characterization of M1- and M2-related phenotypes. Median fluorescence intensity corresponding to (a) M1-related markers TNF- α , IDO enzyme, <t>CCR7,</t> and CD86 and (b) M2-related markers IL-10, arginase I, CD36, and CD163, found in cells harvested from all different polarizing treatments and controls and analyzed by flow cytometry. For THP-1, mock: no stimulated cells; PMA: PMA-only control; M1: PMA + LPS + INF- γ ; M2: PMA + IL-4 + IL-13; and M2 w/o PMA: IL-4 + IL-13. For U937, mock: no stimulated cells; PMA: PMA-only control; M1: PMA + LPS + INF- γ ; M2-A: PMA + IL-4 + IL-13; M2-B: PMA + M-CSF; and M2-C: IL-4 + IL-13. For primary monocytes, mock: no stimulated cells; M1: GM-CSF + LPS + INF- γ ; and M2: M-CSF + IL-4 + IL-13. Asterisks and bars denote statistical significance between conditions. Significant differences ( p ≤ 0.05) found were as follows: in THP-1 cells CD86, M1 versus M2; IL-10, mock versus all the rest of the conditions; arginase I, M1 versus PMA and versus M2 without PMA; CD163, PMA versus all the rest of the conditions and M2 versus M2 without PMA. In U937 cells IDO, M2-A versus mock and versus M2-C; CD86, (PMA, M1, M2-A, and M2-B) versus mock and M2-C; CD163, M1 versus mock and versus M2-C. In primary monocytes IDO and CD86 were significantly different in M1 versus mock and versus M2.
Igg Fraction, supplied by Valiant Co Ltd, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/igg fraction/product/Valiant Co Ltd
Average 95 stars, based on 1 article reviews
igg fraction - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier
apc  (SouthernBiotech)
93
SouthernBiotech apc
Characterization of M1- and M2-related phenotypes. Median fluorescence intensity corresponding to (a) M1-related markers TNF- α , IDO enzyme, <t>CCR7,</t> and CD86 and (b) M2-related markers IL-10, arginase I, CD36, and CD163, found in cells harvested from all different polarizing treatments and controls and analyzed by flow cytometry. For THP-1, mock: no stimulated cells; PMA: PMA-only control; M1: PMA + LPS + INF- γ ; M2: PMA + IL-4 + IL-13; and M2 w/o PMA: IL-4 + IL-13. For U937, mock: no stimulated cells; PMA: PMA-only control; M1: PMA + LPS + INF- γ ; M2-A: PMA + IL-4 + IL-13; M2-B: PMA + M-CSF; and M2-C: IL-4 + IL-13. For primary monocytes, mock: no stimulated cells; M1: GM-CSF + LPS + INF- γ ; and M2: M-CSF + IL-4 + IL-13. Asterisks and bars denote statistical significance between conditions. Significant differences ( p ≤ 0.05) found were as follows: in THP-1 cells CD86, M1 versus M2; IL-10, mock versus all the rest of the conditions; arginase I, M1 versus PMA and versus M2 without PMA; CD163, PMA versus all the rest of the conditions and M2 versus M2 without PMA. In U937 cells IDO, M2-A versus mock and versus M2-C; CD86, (PMA, M1, M2-A, and M2-B) versus mock and M2-C; CD163, M1 versus mock and versus M2-C. In primary monocytes IDO and CD86 were significantly different in M1 versus mock and versus M2.
Apc, supplied by SouthernBiotech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/apc/product/SouthernBiotech
Average 93 stars, based on 1 article reviews
apc - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier

Image Search Results


Characterization of M1- and M2-related phenotypes. Median fluorescence intensity corresponding to (a) M1-related markers TNF- α , IDO enzyme, CCR7, and CD86 and (b) M2-related markers IL-10, arginase I, CD36, and CD163, found in cells harvested from all different polarizing treatments and controls and analyzed by flow cytometry. For THP-1, mock: no stimulated cells; PMA: PMA-only control; M1: PMA + LPS + INF- γ ; M2: PMA + IL-4 + IL-13; and M2 w/o PMA: IL-4 + IL-13. For U937, mock: no stimulated cells; PMA: PMA-only control; M1: PMA + LPS + INF- γ ; M2-A: PMA + IL-4 + IL-13; M2-B: PMA + M-CSF; and M2-C: IL-4 + IL-13. For primary monocytes, mock: no stimulated cells; M1: GM-CSF + LPS + INF- γ ; and M2: M-CSF + IL-4 + IL-13. Asterisks and bars denote statistical significance between conditions. Significant differences ( p ≤ 0.05) found were as follows: in THP-1 cells CD86, M1 versus M2; IL-10, mock versus all the rest of the conditions; arginase I, M1 versus PMA and versus M2 without PMA; CD163, PMA versus all the rest of the conditions and M2 versus M2 without PMA. In U937 cells IDO, M2-A versus mock and versus M2-C; CD86, (PMA, M1, M2-A, and M2-B) versus mock and M2-C; CD163, M1 versus mock and versus M2-C. In primary monocytes IDO and CD86 were significantly different in M1 versus mock and versus M2.

Journal: Journal of Immunology Research

Article Title: Monocyte Differentiation towards Protumor Activity Does Not Correlate with M1 or M2 Phenotypes

doi: 10.1155/2016/6031486

Figure Lengend Snippet: Characterization of M1- and M2-related phenotypes. Median fluorescence intensity corresponding to (a) M1-related markers TNF- α , IDO enzyme, CCR7, and CD86 and (b) M2-related markers IL-10, arginase I, CD36, and CD163, found in cells harvested from all different polarizing treatments and controls and analyzed by flow cytometry. For THP-1, mock: no stimulated cells; PMA: PMA-only control; M1: PMA + LPS + INF- γ ; M2: PMA + IL-4 + IL-13; and M2 w/o PMA: IL-4 + IL-13. For U937, mock: no stimulated cells; PMA: PMA-only control; M1: PMA + LPS + INF- γ ; M2-A: PMA + IL-4 + IL-13; M2-B: PMA + M-CSF; and M2-C: IL-4 + IL-13. For primary monocytes, mock: no stimulated cells; M1: GM-CSF + LPS + INF- γ ; and M2: M-CSF + IL-4 + IL-13. Asterisks and bars denote statistical significance between conditions. Significant differences ( p ≤ 0.05) found were as follows: in THP-1 cells CD86, M1 versus M2; IL-10, mock versus all the rest of the conditions; arginase I, M1 versus PMA and versus M2 without PMA; CD163, PMA versus all the rest of the conditions and M2 versus M2 without PMA. In U937 cells IDO, M2-A versus mock and versus M2-C; CD86, (PMA, M1, M2-A, and M2-B) versus mock and M2-C; CD163, M1 versus mock and versus M2-C. In primary monocytes IDO and CD86 were significantly different in M1 versus mock and versus M2.

Article Snippet: After incubation in the blocking solution 100 μ L of a 1 : 100 dilution in blocking solution of antibodies was added (for panel 1 staining: mouse anti-human anti-CD86-PE and anti-CD163-peridinin­chlorophyll protein complex (PerCP); for panel 2 staining: rat anti-human anti-CD36-fluorescein and mouse anti-human anti-CCR7-PerCP; all antibodies from R&D Systems) and incubated at 4°C for 30 minutes.

Techniques: Fluorescence, Flow Cytometry